The effectiveness and acceptability of prolonged implantation of contraception.
ESC Congress Library. Mheryan A. May 4, 2016; 126972; A-146
Anna Mheryan
Anna Mheryan
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Rate & Comment (0)

Objective. To assess the contraceptive effectiveness and acceptability of prolonged subcutaneous contraceptive that contains 68 mg of etonogestrel (Implanon NCTS®) in women of reproductive age.

Materials and methods. The observation of 48 women aged 19 to 45 years (mean age of women was of 28.0 + 1.7 years) who need effective long-term contraception that meet all the criteria for inclusion and exclusion. Inclusion criteria: reproductive age, the interest in reliable contraception, the absence of contraindications to progestin contraception. Exclusion criteria: contraindications to the use of progestin hormonal contraception medical eligibility criteria the WHO (2009), pregnancy or suspected it, the use of hormonal contraception within the last 3 months, uterine bleeding unclear etiology. Used physical examination, clinical, laboratory, statistical and instrumental methods of examination. The observation period is 1 year.

Results. During the whole observation period in any patient not registered with a pregnancy. Complication during insertion of the implant in the form of hematoma was observed in 1 (2,1%) women. The most common adverse events were changes in the nature of vaginal bleeding. By the end of the first year of using the implant in 11 (22.9%) women was observed amenorrhea, in 17 (35.4 %) experienced occasional spotting, frequent bleeding – 10 (20,8%), prolonged spotting - in 10 (20.8 %). The weight gain on average 2 kg was observed in 2 (4,2%) women. Refused further use of subcutaneous contraceptive during the period of observation - 5 (10,4%) women, mainly due to prolonged and frequent bleeding.

Conclusions. Subcutaneous hormonal implant Implanon NCTS® is an effective and acceptable contraceptive. The most common adverse reactions when using prolonged subcutaneous implant Implanon NCTS® are changing the nature of bleeding, frequency, and duration correlated with the duration of use of contraceptive. The contraceptive implant acceptability is enhanced through counselling prior to prescription of contraceptive.



    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings